Delivery Order SPE2DE24DA017-SPE2D625F2JXQ
- Not listed
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $8,250 by the Defense Logistics Agency's Medical Supply Chain on August 4, 2025, for the Arthrex ACP Double Syringe System. This fixed-price contract with economic price adjustment provisions is scheduled for completion by August 7, 2025, and represents a task order under Arthrex's larger Indefinite Delivery Contract (IDC SPE2DE24D0020) with the Defense...
- Arthrex Inc., a leading global orthopedic medical device manufacturer headquartered in Naples, Florida, was awarded a $8,664.00 fixed-price delivery order for the ARTHREX ACP Double Syringe System by the Defense Logistics Agency's Medical Supply Chain on July 23, 2025. The delivery order, which carries an ultimate completion date of July 28, 2025, represents a task order against Arthrex's existing Indefinite Delivery Contract (SPE2DE24D0020) valued at $471,048,172.66 and running through...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a $17,602.20 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on August 13, 2025, for ARTHREX ACP DOUBLE 1S products. This delivery order, without set-aside designation, is expected to be completed by August 27, 2025, and represents a task order under Arthrex's larger Indefinite Delivery Contract (IDC SPE2DE24D0020) with the Defense Logistics Agency,...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a $24,750 fixed-price delivery order with economic price adjustment for the Arthrex ACP Double Syringe System on September 8, 2025, with an ultimate completion date of September 11, 2025. The award was issued by the Defense Logistics Agency's Medical Supply Chain without a set-aside designation, reflecting Arthrex's competitive strength in the federal marketplace. The product will be...
- Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies headquartered in Naples, Florida, was awarded a delivery order valued at $10,058.80 on August 4, 2025, by the Defense Logistics Agency's Medical Supply Chain. This fixed-price delivery order with economic price adjustment is scheduled for ultimate completion by August 15, 2025, and represents work to be performed at the company's Naples, Florida facility. The award was made without a set-aside designation,...
- Arthrex Inc., a Naples, Florida-based orthopedic medical device manufacturer, received a $3,577.60 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on August 28, 2025, with an ultimate completion date of September 12, 2025. The contract, designated as a non-set-aside award, is issued under Arthrex's existing Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at $471.0 million and running through September 1, 2029. This...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a $2,475 fixed-price delivery order on August 8, 2025, for the Arthrex ACP Double Syringe System. The contract, issued by the Defense Logistics Agency's Medical Supply Chain, carries an ultimate completion date of August 13, 2025, and represents a non-set-aside award. This delivery order falls under the company's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $6,741.00 for an ACP Kit Series I on June 18, 2025, with an ultimate completion date of June 24, 2025. This fixed-price contract with economic price adjustment was issued by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency. The contract carries no set-aside designation, reflecting Arthrex's strong competitive position in...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $1,024.90 by the Defense Logistics Agency's Medical Supply Chain on August 7, 2025, with an ultimate completion date of August 12, 2025. This fixed-price contract with economic price adjustment is a delivery order under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at $471,048,172.66 and running...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $1,758.24 by the Defense Logistics Agency's Medical Supply Chain on August 1, 2025. The contract, issued under a fixed-price arrangement with economic price adjustment provisions, calls for delivery of orthopedic surgical products identified as "FW, BPB #2 SUTR, BLU W/NDL" with a completion deadline of August 6, 2025. This award was not designated...
- SPE2DE24DA017Indefinite Delivery Contract
- SPE2DE24DA017-SPE2D625F2JXQDelivery Order
Arthrex Inc., a Naples, Florida-based orthopedic medical device manufacturer, was awarded a fixed-price delivery order valued at $5,226.00 by the Defense Logistics Agency's Medical Supply Chain on September 3, 2025, for the ARTHREX ACP DOUBLE 1S product. The contract, which is not set-aside, carries an ultimate completion date of September 17, 2025, and represents a task order under Arthrex's larger Indefinite Delivery Contract (IDC SPE2DE24D0020) with the Defense Logistics Agency valued at approximately $471 million through September 2029. This delivery order will be fulfilled at the company's Naples, Florida facility. The award reflects Arthrex's established position as a primary supplier of advanced orthopedic surgical implants and instruments to the Department of Defense and Department of Veterans Affairs. The ACP DOUBLE 1S product is part of the company's broader portfolio of minimally invasive orthopedic solutions, including arthroscopic instruments, joint replacement systems, and specialized surgical kits. As a Subchapter S Corporation registered in the System for Award Management, Arthrex has demonstrated consistent capability in supporting government healthcare systems, with over $550,000 in delivery orders executed to date under its current Defense Logistics Agency contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.2k | 9/3/25 |